Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent Ferrell

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Eclinicalmedicine|June 17, 2025
Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis: a multi-biobank case-control studyJames Brogan, Ashwin Kishtagari, Robert W Corty, et al.
Blood|November 20, 2024
Methylation sequencing enhances interpretation of clonal hematopoiesis dynamicsAlyssa C Parker, Joseph C Van Amburg, J Brett Heimlich, et al.
Cell Reports|July 17, 2025
Integration of phospho-signaling and transcriptomics in single cells reveals distinct Th17 cell fatesSeth D Fortmann, Awalpreet S Chadha, Blake F Frey, et al.
Leukemia & Lymphoma|March 28, 2024
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m<i>IDH1</i>) acute myeloid leukemia (AML)Jorge Cortes, Brian A Jonas, Gary Schiller, et al.
RSC Chemical Biology|February 27, 2026
Discovery of natural products that modulate signaling in patient-derived cellsJoseph A Balsamo, Hannah L Thirman, Kathryn E Penton, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
MDS-associated <i>SF3B1</i> mutations promote aberrant fate choice of hematopoietic stem cell via mis-splicing of mediator kinase module component CDK8Elizabeth A Bonner, Tun-Yun Hsueh, Axia Song, et al.
Nature Chemical Biology|December 3, 2021
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthaseBenjamin J Reisman, Hui Guo, Haley E Ramsey, et al.
Transplantation and Cellular Therapy|March 11, 2023
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid LeukemiaJennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, et al.
Experimental Hematology|September 19, 2025
A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCsPawan Bhat, Joseph C Van Amburg, Chad R Potts, et al.
Experimental Hematology|February 22, 2021
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T Villaume, M Pia Arrate, Haley E Ramsey, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Eclinicalmedicine|June 17, 2025
Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis: a multi-biobank case-control studyJames Brogan, Ashwin Kishtagari, Robert W Corty, et al.
Blood|November 20, 2024
Methylation sequencing enhances interpretation of clonal hematopoiesis dynamicsAlyssa C Parker, Joseph C Van Amburg, J Brett Heimlich, et al.
Cell Reports|July 17, 2025
Integration of phospho-signaling and transcriptomics in single cells reveals distinct Th17 cell fatesSeth D Fortmann, Awalpreet S Chadha, Blake F Frey, et al.
Leukemia & Lymphoma|March 28, 2024
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m<i>IDH1</i>) acute myeloid leukemia (AML)Jorge Cortes, Brian A Jonas, Gary Schiller, et al.
RSC Chemical Biology|February 27, 2026
Discovery of natural products that modulate signaling in patient-derived cellsJoseph A Balsamo, Hannah L Thirman, Kathryn E Penton, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
MDS-associated <i>SF3B1</i> mutations promote aberrant fate choice of hematopoietic stem cell via mis-splicing of mediator kinase module component CDK8Elizabeth A Bonner, Tun-Yun Hsueh, Axia Song, et al.
Nature Chemical Biology|December 3, 2021
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthaseBenjamin J Reisman, Hui Guo, Haley E Ramsey, et al.
Transplantation and Cellular Therapy|March 11, 2023
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid LeukemiaJennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, et al.
Experimental Hematology|September 19, 2025
A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCsPawan Bhat, Joseph C Van Amburg, Chad R Potts, et al.
Experimental Hematology|February 22, 2021
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T Villaume, M Pia Arrate, Haley E Ramsey, et al.
Pageof 5